Diligence memo · auto-generated · as of July 2, 2026

Silicon Vistas 143 LLC

Silicon Vistas 143 LLC looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Silicon Vistas 143 LLC operates in Hardware / Semiconductors, based in FRISCO.

Sub-sector tags: hardware/semi.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Silicon Vistas 143 LLC has raised $11M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $11M on 2023-07-26.

Most recent recorded round closed around 2023-07-27.

Valuation (modeled)modeled

Provath models Silicon Vistas 143 LLC at approximately $67M (range $14M–$179M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.66× the median modeled value of Series A Hardware / Semiconductors companies in 2022–2024 (10 peers) — value vs value, same stage and era. Issuer reports no revenue, yet is modeled well above niche peers.

Financing rhythm & timingmixed

Historic cadence: a new round about every 0 months.

Last raise 2.9 yr ago; this sector typically re-raises about every 16 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

Comparablesmixed

Capital scale ranks ahead of 78% of Hardware / Semiconductors peers (130 compared).

Modeled value ranks above 85% of those peers.

Closest niche peers: Losant IoT, Inc., Sensor Industries Corp., ARCTIC Semiconductor Corp, Inspire Semiconductor, Inc., Deako, Inc..

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.